Scholarly Index
Anne Vincent‐Salomon
Institut Curie; 62,735 total citations; 697 total publications; best world rank #66
Institut Curie
62,735Total citations
697Total publications
110H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Breast Cancer Treatment Studies | Lifetime | 122 | FR 3 | 99.58 |
| Breast Lesions and Carcinomas | Lifetime | 66 | FR 2 | 99.36 |
| Cancer Genomics and Diagnostics | Lifetime | 282 | FR 11 | 99.44 |
| Cancer Cells and Metastasis | Lifetime | 217 | FR 6 | 98.91 |
| HER2/EGFR in Cancer Research | Lifetime | 162 | FR 5 | 99.23 |
| Cancer and Skin Lesions | Lifetime | 155 | FR 7 | 98.50 |
| Cancer Diagnosis and Treatment | Lifetime | 434 | FR 23 | 97.83 |
| Advanced Breast Cancer Therapies | Lifetime | 826 | FR 42 | 93.63 |
| Breast Cancer Treatment Studies | 2021-2025 | 252 | FR 16 | 97.13 |
| Cancer Genomics and Diagnostics | 2021-2025 | 646 | FR 24 | 96.02 |
| Breast Lesions and Carcinomas | 2021-2025 | 120 | FR 3 | 94.18 |
| Cancer Cells and Metastasis | 2021-2025 | 335 | FR 9 | 91.12 |
| HER2/EGFR in Cancer Research | 2021-2025 | 388 | FR 22 | 93.59 |
| Advanced Breast Cancer Therapies | 2021-2025 | 952 | FR 55 | 83.56 |
| Ocular Oncology and Treatments | 2021-2025 | 879 | FR 42 | 64.31 |
| Wnt/β-catenin signaling in development and cancer | 2021-2025 | 686 | FR 11 | 51.18 |